The Accelerated Approvals Process: Are Drugmakers Fulfilling Their Promises?
The Food and Drug Administration allows faster drug approvals based on preliminary study data if the drug fulfills an unmet medical need. But the speedy approval comes with a promise that the drugmaker does another clinical trial once the drug is on the market to prove it really works. If not, the FDA can rescind the…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Short Wave →
Are Your Medications Safe And Effective?, with Jerry Avorn
What to know about the new COVID boosters
Can Psychedelic Therapy Go Mainstream?
The Bumpy Road To Approving New Alzheimer’s Drugs
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.